Literature DB >> 2007701

Prognostic value of thallium-201 myocardial perfusion imaging in patients with unstable angina who respond to medical treatment.

K A Brown1.   

Abstract

Although the prognostic value of thallium-201 imaging is well established, its ability to risk stratify patients who present with unstable angina is unclear. Fifty-two consecutive patients admitted with unstable angina who responded to medical treatment and underwent stress thallium-201 imaging within 1 week of discharge were studied. Patients were followed up for 39 +/- 11 months. Cardiac events included cardiac death (n = 3), nonfatal myocardial infarction (n = 4) and admission for unstable angina or revascularization (n = 17). The ability of thallium-201 data (redistribution, fixed defects, normal) to predict cardiac events was compared with clinical data (age, gender, prior myocardial infarction, anginal syndrome, rest and stress electrocardiogram) and cardiac catheterization data using logistic regression. Thallium-201 redistribution was the only significant predictor of cardiac death or nonfatal myocardial infarction (p less than 0.05). The number of myocardial segments with thallium-201 redistribution (p less than 0.0005) and a history of prior myocardial infarction (p less than 0.05) were the only significant predictors of all cardiac events. Cardiac death or nonfatal myocardial infarction occurred more frequently in patients with thallium-201 redistribution (6 [26%] of 23) than in those without redistribution (1 [3%] of 29, p less than 0.05). Similarly, total cardiac events developed more frequently in patients with thallium-201 redistribution (p less than 0.001). Stress thallium-201 imaging has important prognostic value in patients admitted with unstable angina who respond to medical therapy and can identify subgroups at high versus low risk for future cardiac events.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007701     DOI: 10.1016/0735-1097(91)90829-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

1.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

2.  Reason over reflex in acute ischemic syndromes: the case for a rational application of invasive procedures:.

Authors:  K A Brown
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

3.  Assessing risk in acute chest pain: The value of stress myocardial perfusion imaging in patients admitted through the emergency department.

Authors:  Faisal Nabi; Su Min Chang; Jiaqiong Xu; Elizabeth Gigliotti; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2011-12-07       Impact factor: 5.952

4.  The role of radionuclide myocardial perfusion imaging for asymptomatic individuals.

Authors:  Robert C Hendel; Brian G Abbott; Timothy M Bateman; Ron Blankstein; Dennis A Calnon; Jeffrey A Leppo; Jamshid Maddahi; Matthew M Schumaecker; Leslee J Shaw; R Parker Ward; David G Wolinsky
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

5.  Evaluation of the unstable angina patient in 2005: is there still a role for noninvasive risk stratification?

Authors:  Kenneth A Brown
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

6.  The troponin conundrum: clarification through stress myocardial perfusion SPECT.

Authors:  John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

Review 7.  Myocardial metabolic imaging in the acute care setting.

Authors:  John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

8.  Prognostic value of SPECT myocardial perfusion imaging in patients with elevated cardiac troponin I levels and atypical clinical presentation.

Authors:  Sharmila Dorbala; Robert P Giugliano; Giridhar Logsetty; Divya Vangala; Rakesh Mishra; Sharon Crugnale; David Yang; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

9.  Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease.

Authors:  J H O'Keefe; T M Bateman; R W Ligon; J Case; J Cullom; C Barnhart; J Spertus
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

10.  Gated planar technetium 99m-labeled sestamibi myocardial perfusion image inversion for quantitative scintigraphic assessment of left ventricular function.

Authors:  K A Williams; L A Taillon
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.